Latest Insider Transactions at Liquidia Corp (LQDA)
This section provides a real-time view of insider transactions for Liquidia Corp (LQDA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Liquidia Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Liquidia Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2025
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
831
-0.54%
|
$26,592
$32.19 P/Share
|
|
Dec 01
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
693
-0.39%
|
$22,176
$32.19 P/Share
|
|
Dec 01
2025
|
Dana Boyle Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
303
-0.2%
|
$9,696
$32.19 P/Share
|
|
Dec 01
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
1,166
-0.33%
|
$37,312
$32.19 P/Share
|
|
Dec 01
2025
|
Sarah Krepp Chief Human Resource Officer |
SELL
Open market or private sale
|
Direct |
221
-0.16%
|
$7,072
$32.19 P/Share
|
|
Dec 01
2025
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
1,072
-0.19%
|
$34,304
$32.19 P/Share
|
|
Nov 28
2025
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+1.19%
|
-
|
|
Nov 28
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,563
+0.88%
|
-
|
|
Nov 28
2025
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,343
+0.66%
|
-
|
|
Nov 28
2025
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,343
+0.4%
|
-
|
|
Nov 18
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
35,656
-16.93%
|
$1,069,680
$30.03 P/Share
|
|
Nov 18
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,656
+7.27%
|
$178,280
$5.89 P/Share
|
|
Nov 07
2025
|
Dana Boyle Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
29,004
-8.13%
|
$725,100
$25.11 P/Share
|
|
Nov 05
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
71,381
-14.67%
|
$1,927,287
$27.0 P/Share
|
|
Oct 27
2025
|
Dana Boyle Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,073
-0.58%
|
$23,606
$22.93 P/Share
|
|
Oct 27
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
692
-0.39%
|
$15,224
$22.93 P/Share
|
|
Oct 13
2025
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
7,839
-1.34%
|
$180,297
$23.41 P/Share
|
|
Oct 13
2025
|
Sarah Krepp Chief Human Resource Officer |
SELL
Open market or private sale
|
Direct |
1,691
-1.18%
|
$38,893
$23.41 P/Share
|
|
Oct 13
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
3,670
-2.05%
|
$84,410
$23.41 P/Share
|
|
Oct 13
2025
|
Roger Jeffs Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,261
-1.92%
|
$466,003
$23.41 P/Share
|
|
Oct 13
2025
|
Dana Boyle Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,238
-0.66%
|
$28,474
$23.41 P/Share
|
|
Oct 13
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,327
-2.1%
|
$122,521
$23.41 P/Share
|
|
Oct 13
2025
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,900
-3.09%
|
$112,700
$23.41 P/Share
|
|
Oct 13
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
11,630
-3.19%
|
$267,490
$23.41 P/Share
|
|
Oct 10
2025
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,758
+0.64%
|
-
|
|
Oct 10
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,380
+1.76%
|
-
|
|
Oct 10
2025
|
Roger Jeffs Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,834
+1.3%
|
-
|
|
Oct 10
2025
|
Rajeev Saggar Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,530
+1.37%
|
-
|
|
Oct 10
2025
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,108
+1.92%
|
-
|
|
Oct 10
2025
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,828
+1.57%
|
-
|
|
Sep 15
2025
|
Raman Singh Director |
SELL
Open market or private sale
|
Direct |
45,524
-59.29%
|
$1,138,100
$25.81 P/Share
|
|
Sep 15
2025
|
Raman Singh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,524
+25.84%
|
$91,048
$2.55 P/Share
|
|
Sep 03
2025
|
Raman Singh Director |
SELL
Open market or private sale
|
Direct |
7,500
-19.35%
|
$217,500
$29.42 P/Share
|
|
Sep 02
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
1,148
-0.32%
|
$33,292
$29.05 P/Share
|
|
Sep 02
2025
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
1,063
-0.18%
|
$30,827
$29.05 P/Share
|
|
Sep 02
2025
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
70,692
-10.81%
|
$1,979,376
$28.76 P/Share
|
|
Sep 02
2025
|
Paul B Manning |
SELL
Open market or private sale
|
Indirect |
328,268
-24.08%
|
$9,191,504
$28.91 P/Share
|
|
Sep 02
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
451
-0.26%
|
$13,079
$29.05 P/Share
|
|
Aug 29
2025
|
Dana Boyle Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
296
-0.16%
|
$8,584
$29.05 P/Share
|
|
Aug 29
2025
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.65%
|
-
|
|
Aug 29
2025
|
Sarah Krepp Chief Human Resource Officer |
SELL
Open market or private sale
|
Direct |
209
-0.15%
|
$6,061
$29.05 P/Share
|
|
Aug 29
2025
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.4%
|
-
|
|
Aug 29
2025
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+0.82%
|
-
|
|
Aug 29
2025
|
Paul B Manning |
SELL
Open market or private sale
|
Indirect |
188,232
-19.87%
|
$5,082,264
$27.62 P/Share
|
|
Aug 29
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,562
+0.89%
|
-
|
|
Aug 28
2025
|
Paul B Manning |
SELL
Open market or private sale
|
Indirect |
154,337
-14.01%
|
$4,167,099
$27.94 P/Share
|
|
Aug 28
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-7.41%
|
$540,000
$27.85 P/Share
|
|
Aug 28
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
26,057
-13.22%
|
$703,539
$27.86 P/Share
|
|
Aug 19
2025
|
Joanna Horobin Director |
SELL
Open market or private sale
|
Direct |
5,000
-12.9%
|
$135,000
$27.17 P/Share
|
|
Aug 15
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
20,000
-5.31%
|
$520,000
$26.18 P/Share
|